LWAY Earnings

LWAY reported its earnings on 2026-03-13, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following LWAY's earnings announcement on 2026-03-13, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, LWAY's stock price tends to shift by an average of -4.85% in the 10 days leading up to earnings and 13.05% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate LWAY's annual revenue to reach 57.00M, while the EPS is projected at 0.31. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LWAY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LWAY's stock price typically moves by -4.85% in the 10 days before its earnings and 13.05% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.31 and revenue of 57.00M.

The earnings call highlights several positive aspects: new product launches, market expansion, operational efficiencies, and strategic shifts towards higher-margin products. Despite inflationary pressures, net sales and gross profit margins show growth, and the company anticipates continued volume growth driven by health trends. Investment in production capacity and marketing is expected to support future growth. While risks exist, the overall sentiment is positive, with potential for stock price increase in the short term due to strong strategic initiatives and market positioning.